IRLAB to present at Redeye Theme: Neurology

Gothenburg, October 9, 2026 — IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that CEO Kristina Torfgård will present IRLAB at Redeye Theme: Neurology on October 15 in Stockholm.

IRLAB Appoints Janne Backman as New Chairman of the Board

IRLAB’s CEO intends to step down during the first quarter of 2027